Study Protocol

Published on 16 Sep 2024

Testing home-based exercise strategies in underserved minority cancer patients undergoing chemotherapy (THRIVE) trial: a study protocol

in Breast Cancer

Huimin Yan
Paola Gonzalo-Encabo
Rebekah L. Wilson
Cami N. Christopher
James D. Cannon
Dong-Woo Kang
John Gardiner
Michelle Perez
Mary K. Norris
Daniel Gundersen

Frontiers in Oncology

doi 10.3389/fonc.2024.1427046

1,031 views
1 citation

Original Research

Published on 16 Sep 2024

Lipid profiling of RON and DEK-dependent signaling in breast cancer guides discovery of gene networks predictive of poor outcomes

in Breast Cancer

Sara Vicente-Muñoz
James C. Davis
Adam Lane
Andrew N. Lane
Susan E. Waltz
Susanne I. Wells

Frontiers in Oncology

doi 10.3389/fonc.2024.1382986

683 views

Original Research

Published on 12 Sep 2024

2-methoxyestradiol inhibits the malignant behavior of triple negative breast cancer cells by altering their miRNome

in Breast Cancer

Ramadevi Subramani
Animesh Chatterjee
Diego A. Pedroza
Seeta Poudel
Preetha Rajkumar
Jeffrey Annabi
Elizabeth Penner
Rajkumar Lakshmanaswamy

Frontiers in Oncology

doi 10.3389/fonc.2024.1371792

652 views

Original Research

Published on 12 Sep 2024

Clinicopathological features, treatment patterns, and survival outcomes among Syrian patients with advanced breast cancer

in Breast Cancer

Muhammad Muhammad
Mousa Alali
Maher Saifo

Frontiers in Oncology

doi 10.3389/fonc.2024.1417053

1,160 views

Original Research

Published on 06 Sep 2024

Topical treatment of chemotherapy-induced peripheral neuropathy (CIPN) with high-concentration (179 mg) capsaicin patch in breast cancer patients – results of the QUCIP study

in Breast Cancer

Michael Patrick Lux
Lilit Flöther
Catrin Frömter
Brigitte Rack
Kristina Veselinovic
Myriam Heine
Stefan Paepke
Petra Krabisch
Tamara Quandel
Rainer Sabatowski

Frontiers in Oncology

doi 10.3389/fonc.2024.1452099

1,093 views

Original Research

Published on 02 Sep 2024

Clinical features and prognosis of parotid metastasis of breast cancer: retrospective analysis of 57 cases

in Breast Cancer

Fengli Guo
Honghai Fu
Yuhua Wang
Yitong Hua
Xiaohong Wang
Yingzhe Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1442713

541 views

Review

Published on 02 Sep 2024

New insights into acinic cell carcinoma of the breast: clinicopathology, origin of histology, molecular features, prognosis, and treatment

in Breast Cancer

Yunjie Ge
Xianping Wei
Jing-Nan Liu
Ping-Li Sun
Hongwen Gao

Frontiers in Oncology

doi 10.3389/fonc.2024.1438179

784 views

Systematic Review

Published on 29 Aug 2024

Prognosis in HR-positive metastatic breast cancer with HER2-low versus HER2-zero treated with CDK4/6 inhibitor and endocrine therapy: a meta-analysis

in Breast Cancer

Lin-Yu Xia
Xu-Chen Cao
Qing-Lin Hu
Wei-Yun Xu

Frontiers in Oncology

doi 10.3389/fonc.2024.1413674

779 views
1 citation

Original Research

Published on 29 Aug 2024

Expression profile of messenger and micro RNAs related to the histaminergic system in patients with five subtypes of breast cancer

in Breast Cancer

Tomasz Sirek
Agata Sirek
Marcin Opławski
Dariusz Boroń
Michał Chalcarz
Piotr Ossowski
Konrad Dziobek
Nikola Zmarzły
Damian Strojny
Beniamin Oskar Grabarek

Frontiers in Oncology

doi 10.3389/fonc.2024.1407538

714 views

Original Research

Published on 29 Aug 2024

Influence of H19 polymorphisms on breast cancer: risk assessment and prognostic implications via LincRNA H19/miR-675 and downstream pathways

in Breast Cancer

Ying Qi
Pengfei Zhao

Frontiers in Oncology

doi 10.3389/fonc.2024.1436874

646 views

Original Research

Published on 21 Aug 2024

Pathological response and safety of albumin-bound paclitaxel as a neoadjuvant treatment for HER2-positive breast cancer compared to docetaxel combined with anti-HER2 therapy: a real-world study

in Breast Cancer

Zhidong Lyu
Linlin Gao

Frontiers in Oncology

doi 10.3389/fonc.2024.1412051

767 views

Original Research

Published on 21 Aug 2024

A novel x-Ray and γ-Ray combination strategy for radiotherapy after breast-conserving surgery in patients with right breast cancer

in Breast Cancer

Kunpeng Zhang
Ruixin He
Fenwen Tang
Luping Zhou
Xiaozhi Zhang
Jinsheng Li
Zhiwei Wei
Yi Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1397273

548 views

Case Report

Published on 20 Aug 2024

Case report: A case of giant breast skin warts caused by HPV infection

in Breast Cancer

Chaohui Wang
Yuyang Zhao
Zhenhua Sun
Mingjun Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1422800

731 views

Original Research

Published on 19 Aug 2024

Clinicopathologic significance of heat shock protein 60 as a survival predictor in breast carcinoma

in Breast Cancer

Qing Wang
Shengzhou Chen
Zhihong Wu
Jungang Ni

Frontiers in Oncology

doi 10.3389/fonc.2024.1415762

602 views

Case Report

Published on 16 Aug 2024

Expanding treatment options for patients with HER2+ metastatic breast cancer with margetuximab plus chemotherapy: a case report series

in Breast Cancer

Reshma Mahtani
Natasha Harpalani
Fengting Yan
Kristen Phiel
Iuliia Kovalenko

Frontiers in Oncology

doi 10.3389/fonc.2024.1419246

960 views

Original Research

Published on 16 Aug 2024

Racial/ethnic differences in the clinical presentation and survival of breast cancer by subtype

in Breast Cancer

Vutha Nhim
Alfonso E. Bencomo-Alvarez
Luis Alvarado
Michelle Kilcoyne
Mayra A. Gonzalez-Henry
Idaly M. Olivas
Mehrshad Keivan
Sumit Gaur
Zuber D. Mulla
Alok K. Dwivedi

Frontiers in Oncology

doi 10.3389/fonc.2024.1443399

2,626 views

Navigation group

Articles

Testing home-based exercise strategies in underserved minority cancer patients undergoing chemotherapy (THRIVE) trial: a study protocol

Lipid profiling of RON and DEK-dependent signaling in breast cancer guides discovery of gene networks predictive of poor outcomes

2-methoxyestradiol inhibits the malignant behavior of triple negative breast cancer cells by altering their miRNome

Clinicopathological features, treatment patterns, and survival outcomes among Syrian patients with advanced breast cancer

Topical treatment of chemotherapy-induced peripheral neuropathy (CIPN) with high-concentration (179 mg) capsaicin patch in breast cancer patients – results of the QUCIP study

Clinical features and prognosis of parotid metastasis of breast cancer: retrospective analysis of 57 cases

New insights into acinic cell carcinoma of the breast: clinicopathology, origin of histology, molecular features, prognosis, and treatment

Prognosis in HR-positive metastatic breast cancer with HER2-low versus HER2-zero treated with CDK4/6 inhibitor and endocrine therapy: a meta-analysis

Expression profile of messenger and micro RNAs related to the histaminergic system in patients with five subtypes of breast cancer

Influence of H19 polymorphisms on breast cancer: risk assessment and prognostic implications via LincRNA H19/miR-675 and downstream pathways

Pathological response and safety of albumin-bound paclitaxel as a neoadjuvant treatment for HER2-positive breast cancer compared to docetaxel combined with anti-HER2 therapy: a real-world study

A novel x-Ray and γ-Ray combination strategy for radiotherapy after breast-conserving surgery in patients with right breast cancer

Case report: A case of giant breast skin warts caused by HPV infection

Clinicopathologic significance of heat shock protein 60 as a survival predictor in breast carcinoma

Expanding treatment options for patients with HER2+ metastatic breast cancer with margetuximab plus chemotherapy: a case report series

Racial/ethnic differences in the clinical presentation and survival of breast cancer by subtype